Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysis

Domenico Mallardo; Diana Giannarelli; Maria Grazia Vitale; Domenico Galati; Giusy Trillò; Assunta Esposito; Maria Antonietta Isgrò; Grazia D'Angelo; Lucia Festino; Vito Vanella; Claudia Trojaniello; Andrew White; Teresa De Cristofaro; Michael Bailey; Sandro Pignata; Corrado Caracò; Antonella Petrillo; Paolo Muto; Piera Maiolino; Alfredo Budillon; Sarah Warren; Ernesta Cavalcanti; Paolo Antonio Ascierto

doi:10.1136/jitc-2022-005132

Article metrics

This article has a correction. Please see:

Correction: Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysis - July 01, 2023

PDF

PDF +
Supplementary
Material

Immunotherapy biomarkers

Original research

Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysis

Online download statistics by month:

Online download statistics by month: November 2022 to March 2024

	Abstract	Full	Pdf
Nov 2022	237	241	82
Dec 2022	130	130	41
Jan 2023	145	146	36
Feb 2023	101	102	45
Mar 2023	60	61	20
Apr 2023	51	51	21
May 2023	46	48	18
Jun 2023	45	45	13
Jul 2023	60	61	28
Aug 2023	61	62	12
Sep 2023	38	39	27
Oct 2023	30	30	7
Nov 2023	34	34	10
Dec 2023	30	30	11
Jan 2024	38	40	32
Feb 2024	25	25	17
Mar 2024	42	42	30
Total	1173	1187	450

Log in using your username and password

Main menu

Log in using your username and password

You are here

This article has a correction. Please see:

Online download statistics by month:

Online download statistics by month: November 2022 to March 2024

Read the full text or download the PDF:

Log in using your username and password